I had the pleasure of presenting at the November FDA Office of Women's Health, CBD and Other Cannabinoids. I spoke from a patient's perspective about the challenges of an unregulated CBD market as well as a medical marijuana patient.
I am in the first panel at approximately 57 minutes in.
Comments